• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝脏、胆囊和胆管癌个人合并症的人群归因分数

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers.

作者信息

Hemminki Kari, Sundquist Kristina, Sundquist Jan, Försti Asta, Liska Vaclav, Hemminki Akseli, Li Xinjun

机构信息

Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 323 00 Pilsen, Czech Republic.

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120 Heidelberg, Germany.

出版信息

Cancers (Basel). 2023 Jun 7;15(12):3092. doi: 10.3390/cancers15123092.

DOI:10.3390/cancers15123092
PMID:37370702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10296338/
Abstract

BACKGROUND

We aim to estimate population-attributable fractions (PAF) for 13 comorbidities potentially predisposing to hepatobiliary cancer of hepatocellular carcinoma (HCC), gallbladder cancer (GBC), cancers of the intrahepatic and extrahepatic bile ducts (ICC and ECC), and ampullary cancer.

METHODS

Patients were identified from the Swedish Inpatient Register from 1987 to 2018 and cancers from the Swedish Cancer Registry from 1997 through 2018. PAFs were calculated for each comorbidity-associated cancer using a cohort study design.

RESULTS

For male HCC, the major individual comorbidities (PAF > 10) were diabetes, alcohol-related liver disease, and hepatitis C virus infection. For female HCC, diabetes and autoimmune diseases were important contributors. For female GBC, gallstone disease was an overwhelming contributor, with a PAF of 30.57%, which was also important for men. The overall PAF for male ICC was almost two times higher than the female one. For ECC and ampullary cancer, infection of bile ducts was associated with the highest PAF.

CONCLUSIONS

The 13 comorbidities accounted for 50% or more of the potential etiological pathways of each hepatobiliary cancer except female ICC. The underlying convergent mechanism for these cancers may be chronic inflammation lasting for decades and thus offering possibilities for intervention and disease monitoring.

摘要

背景

我们旨在估算13种共病的人群归因分数(PAF),这些共病可能易引发肝细胞癌(HCC)、胆囊癌(GBC)、肝内和肝外胆管癌(ICC和ECC)以及壶腹癌等肝胆系统癌症。

方法

从1987年至2018年的瑞典住院患者登记册中识别患者,并从1997年至2018年的瑞典癌症登记册中识别癌症病例。使用队列研究设计计算每种与共病相关癌症的PAF。

结果

对于男性HCC,主要的个体共病(PAF>10)为糖尿病、酒精性肝病和丙型肝炎病毒感染。对于女性HCC,糖尿病和自身免疫性疾病是重要因素。对于女性GBC,胆结石病是主要因素,PAF为30.57%,对男性也很重要。男性ICC的总体PAF几乎是女性的两倍。对于ECC和壶腹癌,胆管感染与最高的PAF相关。

结论

除女性ICC外,这13种共病占每种肝胆系统癌症潜在病因途径的50%或更多。这些癌症潜在的共同机制可能是持续数十年的慢性炎症,从而为干预和疾病监测提供了可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/a0e7538e61be/cancers-15-03092-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/e08fa77df6f2/cancers-15-03092-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/047e2a397b00/cancers-15-03092-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/b798dcd0c289/cancers-15-03092-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/a0e7538e61be/cancers-15-03092-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/e08fa77df6f2/cancers-15-03092-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/047e2a397b00/cancers-15-03092-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/b798dcd0c289/cancers-15-03092-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a38a/10296338/a0e7538e61be/cancers-15-03092-g004.jpg

相似文献

1
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers.肝脏、胆囊和胆管癌个人合并症的人群归因分数
Cancers (Basel). 2023 Jun 7;15(12):3092. doi: 10.3390/cancers15123092.
2
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.个人共病情况及其后续发生肝癌、胆囊癌和胆管癌的风险。
Int J Cancer. 2023 Mar 15;152(6):1107-1114. doi: 10.1002/ijc.34308. Epub 2022 Oct 10.
3
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden.自身免疫性疾病作为瑞典肝脏、胆囊和胆管癌的合并症
Cancer. 2023 Jan 30. doi: 10.1002/cncr.34663.
4
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country.瑞典(一个低发病率国家)肝脏、胆囊和胆管癌及其风险因素的家族风险。
Cancers (Basel). 2022 Apr 12;14(8):1938. doi: 10.3390/cancers14081938.
5
Population attributable fractions of risk factors for hepatocellular carcinoma in the United States.美国肝细胞癌风险因素的人群归因分数
Cancer. 2016 Jun 1;122(11):1757-65. doi: 10.1002/cncr.29971. Epub 2016 Mar 21.
6
Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease.住院治疗自身免疫性疾病后肝胆癌风险增加。
Clin Gastroenterol Hepatol. 2014 Jun;12(6):1038-45.e7. doi: 10.1016/j.cgh.2013.11.007. Epub 2013 Nov 15.
7
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.丙型肝炎病毒感染后发生肝胆胰癌症的风险:一项基于美国退伍军人人群的研究。
Hepatology. 2009 Jan;49(1):116-23. doi: 10.1002/hep.22606.
8
[Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].[性别特异性对肝癌、胆囊癌、肝外胆管癌和胰腺癌发病率、危险因素及预后的影响因素]
Zentralbl Chir. 2014 Apr;139(2):184-92. doi: 10.1055/s-0034-1368231. Epub 2014 Apr 28.
9
The relationship between vegetable/fruit consumption and gallbladder/bile duct cancer: A population-based cohort study in Japan.蔬菜/水果摄入量与胆囊/胆管癌之间的关系:一项基于日本人群的队列研究。
Int J Cancer. 2017 Mar 1;140(5):1009-1019. doi: 10.1002/ijc.30492. Epub 2016 Nov 29.
10
Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.新西兰的胆囊癌、肝外胆管癌和壶腹癌:人口统计学、病理学与生存率
ANZ J Surg. 2002 Dec;72(12):857-61. doi: 10.1046/j.1445-2197.2002.02589.x.

引用本文的文献

1
Identifying risk factors of biliary tract cancers using a large Japanese regional insurance claims database.利用一个大型日本地区保险理赔数据库确定胆道癌的风险因素。
Sci Rep. 2025 Jul 8;15(1):24347. doi: 10.1038/s41598-025-09790-6.
2
Prevalence of New-Onset Diabetes in Patients Undergoing Pancreatic Surgery and the Association of Glucose Dysregulation With Complications in Pancreatic Cancer.接受胰腺手术患者新发糖尿病的患病率以及血糖失调与胰腺癌并发症的关联
Ann Surg Open. 2025 Jun 11;6(2):e584. doi: 10.1097/AS9.0000000000000584. eCollection 2025 Jun.
3
Long-term weight change patterns in American adulthood in relation to gallstones: evidence from NHANES.

本文引用的文献

1
Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.北欧国家实体瘤长期生存趋势标志着改善时机。
Int J Cancer. 2023 May 1;152(9):1837-1846. doi: 10.1002/ijc.34416. Epub 2023 Jan 13.
2
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.美国胆道癌的流行病学模式:2001-2015 年。
BMC Cancer. 2022 Nov 16;22(1):1178. doi: 10.1186/s12885-022-10286-z.
3
Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries.北欧原发性肝癌和胰腺癌的长期生存趋势。
美国成年人长期体重变化模式与胆结石的关系:来自美国国家健康与营养检查调查(NHANES)的证据
BMC Gastroenterol. 2025 Apr 12;25(1):250. doi: 10.1186/s12876-025-03846-7.
4
Integrated Pleiotropic Gene Set Unveils Comorbidity Insights across Digestive Cancers and Other Diseases.整合多效基因集揭示消化系统癌症及其他疾病的共病见解。
Genes (Basel). 2024 Apr 10;15(4):478. doi: 10.3390/genes15040478.
5
miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma.微小RNA和长链非编码RNA作为肝细胞癌潜在的组织生物标志物
Noncoding RNA Res. 2023 Oct 24;9(1):24-32. doi: 10.1016/j.ncrna.2023.10.010. eCollection 2024 Mar.
JHEP Rep. 2022 Sep 29;4(12):100602. doi: 10.1016/j.jhepr.2022.100602. eCollection 2022 Dec.
4
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.个人共病情况及其后续发生肝癌、胆囊癌和胆管癌的风险。
Int J Cancer. 2023 Mar 15;152(6):1107-1114. doi: 10.1002/ijc.34308. Epub 2022 Oct 10.
5
Survival trends in solid cancers in the Nordic countries through 50 years.50 年来北欧国家实体瘤的生存趋势。
Eur J Cancer. 2022 Nov;175:77-85. doi: 10.1016/j.ejca.2022.08.015. Epub 2022 Sep 9.
6
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country.瑞典(一个低发病率国家)肝脏、胆囊和胆管癌及其风险因素的家族风险。
Cancers (Basel). 2022 Apr 12;14(8):1938. doi: 10.3390/cancers14081938.
7
Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast?丹麦、芬兰、挪威和瑞典的肝细胞癌和肝内胆管癌的长期发病率,Thorotrast 的作用?
Int J Cancer. 2022 Aug 15;151(4):510-517. doi: 10.1002/ijc.34031. Epub 2022 Apr 29.
8
Long-term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast.丹麦、芬兰、挪威和瑞典的胆囊和肝外胆管癌的长期发病和生存趋势及其与 Thorotrast 相关的病因学意义。
Int J Cancer. 2022 Jul 15;151(2):200-208. doi: 10.1002/ijc.33980. Epub 2022 Mar 3.
9
Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.阿司匹林预防肝细胞癌:一项更新的荟萃分析,特别关注慢性肝病患者。
Eur J Clin Pharmacol. 2022 Apr;78(4):647-656. doi: 10.1007/s00228-021-03247-1. Epub 2022 Jan 15.
10
Advancing the global public health agenda for NAFLD: a consensus statement.推进非酒精性脂肪性肝病的全球公共卫生议程:共识声明。
Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27.